Effect of the medication Buspirone Hydrochloride on the frequency of teeth grinding secondary to Anxiety

Phase 3

Recruiting

• Conditions: Temporomandibular joint disorders; Bruxism; F411

• Registration Number: RBR-37yq8r6
• Lead Sponsor: niversidade Federal do Paraná

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-05-24
• Last Update Posted: 29 May 2023
• Study Completion: 2023-07-30

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Both sexes; Older than 18 years; Diagnosis of probable sleep bruxism and definite awake bruxism

Exclusion Criteria

Under 18 years old; Epilepsy and seizure; Acute intoxication and/or chronic use of alcohol, hypnotics, analgesics, or antipsychotic drugs; Smokers; Consumption of more than three cups of coffee per day; Severe kidney and liver failure;
• Severe neurological or psychiatric disorders; History of chronic musculoskeletal pain; Previous diagnosis or signs and symptoms of chronic TMD and sleep disorders (snoring, sleep apnea, and periodic limb movement); Use of prescription drugs or drugs with possible effects on sleep or changes in motor behavior or drug interactions with buspirone hydrochloride; Gastroesophageal reflux; Enlarged tonsils; BMI > 30; Allergy to electrode gel; Currently undergoing medical or dental treatment; Pregnant women; Users of pacemaker or implanted defibrillator; Loss of more than two posterior teeth, except third molars; Users of complete dentures, removable partial dentures and orthodontic appliances; Skeletal Class II

Study & Design

• Study Type: Intervention
• Study Design: Not specified